LIANA KELLY: Open Payments
NPI 1649312638 · SCARBOROUGH, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,142 in 23 payments from 8 companies in 2025. Trend: 2023 $793 · 2024 $483 · 2025 $1,142
Food & beverage: $1,142
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 8 | $316 |
| Abbott Laboratories | 4 | $194 |
| Novo Nordisk Inc | 2 | $174 |
| Tandem Diabetes Care, Inc. | 2 | $168 |
| Madrigal Pharmaceuticals | 1 | $134 |
| BETA BIONICS, INC. | 4 | $78 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $58 |
| Sequel Med Tech, LLC | 1 | $20 |
Products named: FREESTYLE LIBRE 3, t:slim X2 Insulin Pump with Control-IQ, Dexcom G6 Transmitter, DEXCOM G7 GSS (161), REZDIFFRA, Ozempic, iLet Bionic Pancreas, JARDIANCE.
Industry payments across ME — which companies pay providers there.
